Intervention of hIAPP amyloid aggregation by smart posttransmuting anti-amyloidogenic peptidomimetics | Synapse
April 10, 2026
Intervention of hIAPP amyloid aggregation by smart posttransmuting anti-amyloidogenic peptidomimetics
Key Points
The research aims to explore innovative peptidomimetics that can prevent the aggregation of hIAPP, linking this process to T2DM.
Investigated various peptidomimetics for their effects on hIAPP aggregation.
Utilized in vitro models to simulate amyloid formation.
Analyzed the efficacy of selected compounds on amyloid suppression.
Certain peptidomimetics demonstrated a significant reduction in hIAPP aggregation.
The findings suggest a promising avenue for therapeutic intervention in T2DM.
Abstract
hIAPP, human islet amyloid polypeptide, aggregates have been implicated in the development of type 2 diabetes mellitus (T2DM). As a prelude to developing a potential cure for T2DM, researchers worldwide...